Literature DB >> 15174031

Increased beta-Secretase activity in cerebrospinal fluid of Alzheimer's disease subjects.

R M Damian Holsinger, Catriona A McLean, Steven J Collins, Colin L Masters, Geneviève Evin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15174031     DOI： 10.1002/ana.20144

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  36 in total

Review 1.  Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.

Authors:  Harald Hampel; Richard Frank; Karl Broich; Stefan J Teipel; Russell G Katz; John Hardy; Karl Herholz; Arun L W Bokde; Frank Jessen; Yvonne C Hoessler; Wendy R Sanhai; Henrik Zetterberg; Janet Woodcock; Kaj Blennow
Journal:  Nat Rev Drug Discov       Date:  2010-07       Impact factor: 84.694

Review 2.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

3.  Variation in RTN3 and PPIL2 genes does not influence platelet membrane beta-secretase activity or susceptibility to alzheimer's disease in the northern Irish population.

Authors:  Robyn Carson; Amy Jayne McKnight; Stephen Todd; Wei Wei Liu; Shirley Heggarty; David Craig; Bernadette McGuinness; G Brent Irvine; A Peter Passmore; Janet A Johnston
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

Review 4.  Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.

Authors:  Harald Hampel; Yong Shen; Dominic M Walsh; Paul Aisen; Les M Shaw; Henrik Zetterberg; John Q Trojanowski; Kaj Blennow
Journal:  Exp Neurol       Date:  2009-10-06       Impact factor: 5.330

5.  CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.

Authors:  Jeremy Koppel; Fabien Campagne; Valérie Vingtdeux; Ute Dreses-Werringloer; Michael Ewers; Dan Rujescu; Harald Hampel; Marc L Gordon; Erica Christen; Julien Chapuis; Blaine S Greenwald; Peter Davies; Philippe Marambaud
Journal:  Mol Med       Date:  2011-05-24       Impact factor: 6.354

Review 6.  Splice variants of the Alzheimer's disease beta-secretase, BACE1.

Authors:  R M Damian Holsinger; Nelleke Goense; John Bohorquez; Padraig Strappe
Journal:  Neurogenetics       Date:  2012-11-11       Impact factor: 2.660

7.  Characterization of Cerebrospinal Fluid BACE1 Species.

Authors:  Inmaculada Lopez-Font; Claudia P Boix; Henrik Zetterberg; Kaj Blennow; Javier Sáez-Valero
Journal:  Mol Neurobiol       Date:  2019-07-09       Impact factor: 5.590

Review 8.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

9.  Evidence for natural antisense transcript-mediated inhibition of microRNA function.

Authors:  Mohammad Ali Faghihi; Ming Zhang; Jia Huang; Farzaneh Modarresi; Marcel P Van der Brug; Michael A Nalls; Mark R Cookson; Georges St-Laurent; Claes Wahlestedt
Journal:  Genome Biol       Date:  2010-05-27       Impact factor: 13.583

10.  Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.

Authors:  Mohammad Ali Faghihi; Farzaneh Modarresi; Ahmad M Khalil; Douglas E Wood; Barbara G Sahagan; Todd E Morgan; Caleb E Finch; Georges St Laurent; Paul J Kenny; Claes Wahlestedt
Journal:  Nat Med       Date:  2008-06-29       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.